Vincenzo Silani

Vincenzo Silani's AcademicInfluence.com Rankings

Vincenzo Silani

Biology

#13496

World Rank

#17044

Historical Rank

Neuroscience

#2346

World Rank

#2410

Historical Rank

biology Degrees

Download Badge

Biology

Vincenzo Silani's Degrees

PhD Neuroscience University of Milan
Doctorate Medicine University of Milan

Why Is Vincenzo Silani Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Vincenzo Silani's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease (2001) (1325)
EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force (2012) (868)
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways (2015) (816)
Mutations in the Profilin 1 Gene Cause Familial Amyotrophic Lateral Sclerosis (2012) (547)
Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria (2017) (511)
TDP‐43 is recruited to stress granules in conditions of oxidative insult (2009) (453)
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis (2016) (424)
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene (2018) (414)
A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis (1998) (322)
EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives (2005) (280)
Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS (2014) (262)
TDP-43 and FUS RNA-binding Proteins Bind Distinct Sets of Cytoplasmic Messenger RNAs and Differently Regulate Their Post-transcriptional Fate in Motoneuron-like Cells* (2012) (249)
Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study (2010) (247)
Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved? (2014) (232)
Neuro-glial differentiation of human bone marrow stem cells in vitro (2005) (217)
The Survival of Motor Neuron (SMN) Protein Interacts with the mRNA-Binding Protein HuD and Regulates Localization of Poly(A) mRNA in Primary Motor Neuron Axons (2011) (213)
The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder (2012) (213)
High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis (2009) (210)
Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity (2001) (202)
Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis (2009) (197)
Good practice in the management of amyotrophic lateral sclerosis: Clinical guidelines. An evidence‐based review with good practice points. EALSC Working Group (2007) (197)
Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis (2017) (196)
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis (2016) (195)
Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis (2011) (184)
Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential (2006) (182)
Mutations of FUS gene in sporadic amyotrophic lateral sclerosis (2009) (176)
Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis (2017) (167)
Stem-cell therapy for amyotrophic lateral sclerosis (2004) (163)
Huntington's disease: The current state of research with peripheral tissues (2009) (162)
CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia (2016) (160)
The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease (2015) (151)
Transplantation of Undifferentiated Human Mesenchymal Stem Cells Protects against 6-Hydroxydopamine Neurotoxicity in the Rat (2010) (144)
Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort (2009) (143)
Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis (2018) (139)
Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease (2010) (132)
Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families (2000) (130)
Mitochondrial respiratory chain dysfunction in muscle from patients with amyotrophic lateral sclerosis. (2010) (128)
The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS) (2016) (124)
The Present and the Future of Neuroimaging in Amyotrophic Lateral Sclerosis (2010) (124)
Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts (2016) (122)
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. (2014) (121)
Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis (2018) (119)
A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group. (1998) (116)
Phase II/III randomized trial of TCH346 in patients with ALS (2007) (114)
Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options (2013) (112)
A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories (2014) (111)
Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European survey (2001) (111)
Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS/MND: Report on the 142nd ENMC international workshop (2007) (108)
Increased apoptosis, huntingtin inclusions and altered differentiation in muscle cell cultures from Huntington's disease subjects (2006) (108)
Identification of new ANG gene mutations in a large cohort of Italian patients with amyotrophic lateral sclerosis (2008) (107)
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia (2017) (107)
Production of monocyte chemoattractant protein‐1 in amyotrophic lateral sclerosis (2005) (106)
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (2021) (104)
Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis (2011) (103)
Dysphagia in amyotrophic lateral sclerosis: prevalence and clinical findings (2013) (102)
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials (2019) (99)
Induction of Neurotrophin Expression via Human Adult Mesenchymal Stem Cells: Implication for Cell Therapy in Neurodegenerative Diseases (2007) (99)
Novel mutations support a role for Profilin 1 in the pathogenesis of ALS (2015) (97)
C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect (2012) (96)
UFD1L, a developmentally expressed ubiquitination gene, is deleted in CATCH 22 syndrome. (1997) (92)
Factors predicting survival in ALS: a multicenter Italian study (2016) (91)
Lithium carbonate in amyotrophic lateral sclerosis (2010) (90)
A role for the ELAV RNA-binding proteins in neural stem cells: stabilization of Msi1 mRNA (2006) (87)
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double- blind, randomized, multicentre, placebo-controlled trial (2009) (85)
Primary lateral sclerosis: consensus diagnostic criteria (2020) (83)
Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS (2016) (80)
EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases (2010) (79)
Neuropsychiatric Burden in Huntington’s Disease (2017) (77)
cDNA characterization and chromosomal mapping of two human homologues of the Drosophila dishevelled polarity gene. (1996) (74)
Long-Lasting Cognitive Abnormalities after COVID-19 (2021) (74)
Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia (2012) (74)
Brain-Computer Interface for Clinical Purposes: Cognitive Assessment and Rehabilitation (2017) (74)
Telepsychotherapy: a leaflet for psychotherapists in the age of COVID-19. A review of the evidence (2020) (72)
Paraoxonase gene mutations in amyotrophic lateral sclerosis (2010) (72)
Intrahemispheric and interhemispheric structural network abnormalities in PLS and ALS (2014) (71)
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial. (2014) (69)
Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF72‐associated amyotrophic lateral sclerosis (2017) (69)
Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy (2021) (69)
CHCHD10 mutations in Italian patients with sporadic amyotrophic lateral sclerosis. (2015) (68)
The use of P300-based BCIs in amyotrophic lateral sclerosis: from augmentative and alternative communication to cognitive assessment (2012) (68)
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS (2013) (66)
Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis (2014) (66)
Nutritional management in amyotrophic lateral sclerosis: a worldwide perspective (1998) (65)
Post-transcriptional Regulation of Neuro-oncological Ventral Antigen 1 by the Neuronal RNA-binding Proteins ELAV* (2008) (65)
A Review of Options for Treating Sialorrhea in Amyotrophic Lateral Sclerosis (2015) (62)
Low Anaerobic Threshold and Increased Skeletal Muscle Lactate Production in Subjects with Huntington's Disease (2010) (61)
Repeated courses of granulocyte colony‐stimulating factor in amyotrophic lateral sclerosis: Clinical and biological results from a prospective multicenter study (2011) (61)
Mutational analysis of TARDBP in neurodegenerative diseases (2011) (60)
Validating the Neuro VR-Based Virtual Version of the Multiple Errands Test: Preliminary Results (2012) (60)
ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function (2018) (60)
Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis. (2016) (58)
Non-neural phenotype of spinal and bulbar muscular atrophy: results from a large cohort of Italian patients (2015) (56)
ELAV proteins along evolution: Back to the nucleus? (2013) (56)
C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: A genome‐wide meta‐analysis (2014) (56)
Superoxide dismutase gene mutations in Italian patients with familial and sporadic amyotrophic lateral sclerosis: identification of three novel missense mutations (2001) (55)
Human homologue sequences to the Drosophila dishevelled segment-polarity gene are deleted in the DiGeorge syndrome. (1996) (55)
Molecular signatures of amyotrophic lateral sclerosis disease progression in hind and forelimb muscles of an SOD1(G93A) mouse model. (2012) (55)
Intracerebroventricular administration of human umbilical cord blood cells delays disease progression in two murine models of motor neuron degeneration. (2011) (48)
Human neuronal cell viability demonstrated in culture after cryopreservation (1988) (47)
Protein aggregation and defective RNA metabolism as mechanisms for motor neuron damage. (2010) (47)
Impaired Expression of Insulin-Like Growth Factor-1 System in Skeletal Muscle of Amyotrophic Lateral Sclerosis Patients (2012) (47)
Amyotrophic lateral sclerosis and frontotemporal dementia (ALS-FTD). (2011) (46)
Aripiprazole in the treatment of Huntington’s disease: a case series (2008) (45)
Genetics of familial Amyotrophic lateral sclerosis. (2011) (45)
An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID) (2020) (45)
The diagnosis of Amyotrophic lateral sclerosis in 2010. (2011) (44)
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence (2014) (44)
TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations (2015) (43)
Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia (2013) (42)
Pilot trial of clenbuterol in spinal and bulbar muscular atrophy (2013) (40)
Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis (2020) (40)
From transcriptomic to protein level changes in TDP-43 and FUS loss-of-function cell models. (2015) (40)
Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS (2014) (39)
Resting state functional connectivity alterations in primary lateral sclerosis (2014) (39)
Amyotrophic lateral sclerosis care in Italy: a nationwide study in neurological centers (2001) (39)
Different mutations at V363 MAPT codon are associated with atypical clinical phenotypes and show unusual structural and functional features (2014) (38)
Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial. (2010) (37)
Dose Dependent Side Effect of Superparamagnetic Iron Oxide Nanoparticle Labeling on Cell Motility in Two Fetal Stem Cell Populations (2013) (37)
Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons (2020) (37)
Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy (2013) (37)
Extramotor Damage Is Associated with Cognition in Primary Lateral Sclerosis Patients (2013) (37)
No association of DPP6 with amyotrophic lateral sclerosis in an Italian population (2011) (37)
July 2017 ENCALS statement on edaravone (2017) (36)
The synaptic function of parkin (2017) (36)
Parkin regulates kainate receptors by interacting with the GluK2 subunit (2014) (36)
ATAXIN2 CAG-repeat length in Italian patients with amyotrophic lateral sclerosis: risk factor or variant phenotype? Implication for genetic testing and counseling (2012) (36)
Wake-up stroke and TIA due to paradoxical embolism during long obstructive sleep apnoeas: a cross-sectional study (2012) (35)
Clinical and pathological features in hydrocarbon‐induced Parkinsonism (1996) (35)
Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS) (2019) (35)
Development of Dopaminergic Neurons in the Human Mesencephalon and in Vitro Effects of Basic Fibroblast Growth Factor Treatment (1994) (35)
TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients (2020) (34)
Cognitive-behavioral longitudinal assessment in ALS: the Italian Edinburgh Cognitive and Behavioral ALS screen (ECAS) (2018) (34)
Stem cell therapy for neurodegenerative diseases: the issue of transdifferentiation. (2004) (33)
Metabolic impairment and membrane abnormality in red cells from Huntington's disease (1980) (33)
Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: implications for reparative therapy in Parkinson’s disease (2012) (32)
Expression study of survival motor neuron gene in human fetal tissues. (1997) (32)
RNA-binding proteins and RNA metabolism: a new scenario in the pathogenesis of Amyotrophic lateral sclerosis. (2011) (31)
Morphological differentiation of astroglial progenitor cells from EGF-responsive neurospheres in response to fetal calf serum, basic fibroblast growth factor, and retinol. (1996) (31)
Provisional best practices guidelines for the evaluation of bulbar dysfunction in amyotrophic lateral sclerosis (2019) (31)
Plasma exchange ineffective in amyotrophic lateral sclerosis. (1980) (31)
C9orf72 repeat expansions are restricted to the ALS-FTD spectrum (2014) (31)
Defining the role of the Bcl-2 family proteins in Huntington's disease (2013) (30)
Metalloproteinase alterations in the bone marrow of ALS patients (2010) (30)
Rising evidence for neurological involvement in COVID-19 pandemic (2020) (30)
Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson’s disease (2012) (30)
Longitudinal Tracking of Human Fetal Cells Labeled with Super Paramagnetic Iron Oxide Nanoparticles in the Brain of Mice with Motor Neuron Disease (2012) (29)
Charles Bonnet syndrome: two case reports and review of the literature (2013) (29)
Validation of a Neuro Virtual Reality-based Version of the Multiple Errands Test for the Assessment of Executive Functions (2011) (29)
A tentative interpretation of electromyographic regional differences in bulbar- and limb-onset ALS (1999) (29)
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. (2016) (29)
Honesty and hope: announcement of diagnosis in ALS. (1999) (29)
Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis (2013) (29)
Focus on the heterogeneity of amyotrophic lateral sclerosis (2020) (29)
New technologies and Amyotrophic Lateral Sclerosis – Which step forward rushed by the COVID-19 pandemic? (2020) (28)
Biocompatible fluorescent nanoparticles for in vivo stem cell tracking (2013) (28)
Comparative Analysis of C9orf72 and Sporadic Disease in a Large Multicenter ALS Population: The Effect of Male Sex on Survival of C9orf72 Positive Patients (2019) (28)
Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia (2021) (28)
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis (2021) (27)
Stem cells in the treatment of amyotrophic lateral sclerosis (ALS) (2002) (27)
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis (2021) (27)
C9orf72 and UNC13A are shared risk loci for ALS and FTD: A genome-wide meta-analysis (2014) (26)
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (2021) (26)
Oligoclonal bands in the cerebrospinal fluid of amyotrophic lateral sclerosis patients with disease-associated mutations (2012) (26)
Understanding the use of NIV in ALS: results of an international ALS specialist survey (2018) (26)
The combined use of Brain Computer Interface and Eye-Tracking technology for cognitive assessment in Amyotrophic Lateral Sclerosis (2011) (25)
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis (2018) (25)
Mutational analysis of VCP gene in familial amyotrophic lateral sclerosis (2012) (25)
Human salivary Raman fingerprint as biomarker for the diagnosis of Amyotrophic Lateral Sclerosis (2020) (25)
Real life evaluation of safinamide effectiveness in Parkinson’s disease (2018) (24)
Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study (2014) (24)
Neurorescue effects and stem properties of chorionic villi and amniotic progenitor cells (2013) (24)
Motor neurones in culture as a model to study ALS (2000) (24)
Dysregulated IGFBP5 expression causes axon degeneration and motoneuron loss in diabetic neuropathy (2015) (24)
Stem cells in amyotrophic lateral sclerosis: motor neuron protection or replacement? (2010) (24)
Reconsidering the causality of TIA1 mutations in ALS (2018) (23)
Mutant Huntingtin induces activation of the Bcl-2/adenovirus E1B 19-kDa interacting protein (BNip3) (2010) (23)
Isolation and characterization of a novel transcript embedded within HIRA, a gene deleted in DiGeorge syndrome. (1999) (23)
Cell-replacement therapy with stem cells in neurodegenerative diseases. (2004) (23)
One‐year cognitive follow‐up of COVID‐19 hospitalized patients (2022) (23)
X-linked Parkinsonism with Intellectual Disability caused by novel mutations and somatic mosaicism in RAB39B gene. (2017) (23)
Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS (2021) (23)
Elevated Global DNA Methylation Is Not Exclusive to Amyotrophic Lateral Sclerosis and Is Also Observed in Spinocerebellar Ataxia Types 1 and 2 (2018) (22)
Free insulin‐like growth factor (IGF)‐1 and IGF‐binding proteins‐2 and ‐3 in serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients (2010) (22)
Intracerebral haemorrhage, a possible presentation in Churg-Strauss syndrome: Case report and review of the literature (2011) (22)
Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk Gene (2020) (22)
An eye-tracker controlled cognitive battery: overcoming verbal-motor limitations in ALS (2017) (21)
The role of clinical and neuroimaging features in the diagnosis of CADASIL (2018) (21)
A genome-wide association meta-analysis identifies a novel locus at 17 q 11 . 2 associated with sporadic amyotrophic lateral sclerosis (2014) (21)
Implementation of the multiple errands test in a NeuroVR-supermarket: a possible approach. (2010) (21)
Phenotypic Modulation and Neuroprotective Effects of Olfactory Ensheathing Cells: a Promising Tool for Cell Therapy (2016) (21)
The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial (2021) (20)
Stem therapy for ALS: hope and reality. (2003) (20)
Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus (2016) (20)
Genetic analysis of the SOD1 and C9ORF72 genes in Hungarian patients with amyotrophic lateral sclerosis (2017) (20)
Safety and Efficacy of the New Micromesh-Covered Stent CGuard in Patients Undergoing Carotid Artery Stenting: Early Experience From a Single Centre. (2017) (19)
Ras P21 protein promotes survival and differentiation of human embryonic neural crest-derived cells (1996) (19)
Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial) (2017) (19)
Prevalence of Huntington's disease gene CAG repeat alleles in sporadic amyotrophic lateral sclerosis patients (2012) (19)
Motor neuron differentiation of iPSCs obtained from peripheral blood of a mutant TARDBP ALS patient. (2018) (19)
Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS (2022) (18)
A NeuroVR based tool for cognitive assessment and rehabilitation of post-stroke patients: two case studies (2009) (18)
Stem cell transplantation in Multiple Sclerosis: Safety and Ethics (2008) (18)
Effect of nerve growth factor in adrenal autografts in parkinsonism (1990) (18)
An eye-tracking controlled neuropsychological battery for cognitive assessment in neurological diseases (2017) (18)
Age at onset in sod1-mediated amyotrophic lateral sclerosis shows familiality (2007) (18)
Manifesting carrier of X-linked Duchenne muscular dystrophy (1981) (17)
Obstructive sleep apnea syndrome: a cause of acute delirium. (2009) (17)
NMR Metabolomics for Stem Cell type discrimination (2017) (16)
CHCHD 10 mutations in Italian patients with sporadic amyotrophic lateral sclerosis (2015) (16)
Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis (2022) (16)
Attachment, Personality and Locus of Control: Psychological Determinants of Risk Perception and Preventive Behaviors for COVID-19 (2021) (16)
The Arrows and Colors Cognitive Test (ACCT): A new verbal-motor free cognitive measure for executive functions in ALS (2018) (16)
Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation (2018) (16)
Neurochemical biomarkers in amyotrophic lateral sclerosis. (2019) (16)
No evidence of cardiomyopathy in spinal and bulbar muscular atrophy (2013) (16)
The pseudopolyneuritic form of amyotrophic lateral sclerosis (Patrikios' disease). (2008) (15)
Dysgraphia in Patients with Primary Lateral Sclerosis: A Speech-Based Rehearsal Deficit? (2008) (15)
Cognitive assessment in Amyotrophic Lateral Sclerosis by means of P300-Brain Computer Interface: a preliminary study (2016) (15)
The emerging picture of ALS: a multisystem, not only a "motor neuron disease. (2017) (15)
Stem Cell Therapy for ALS: Hope and RealityA discussion paper from the Executive of the European ALS Consortium (2003) (15)
Immunomagnetic isolation of human developing motor neurons (1998) (15)
STEM CELL THERAPY FOR ALS: HOPE and REALITY (2003) (14)
The Complex Interplay Between Depression/Anxiety and Executive Functioning: Insights From the ECAS in a Large ALS Population (2018) (14)
You stole my food! Eating alterations in frontotemporal dementia (2016) (14)
Progression of brain functional connectivity and frontal cognitive dysfunction in ALS (2020) (14)
Association between renin-angiotensin-aldosterone system inhibitors and risk of dementia: a meta-analysis. (2021) (14)
Bartolomeo Panizza and the discovery of the brain's visual center. (2000) (14)
Pyrimethamine significantly lowers cerebrospinal fluid Cu/Zn superoxide dismutase in amyotrophic lateral sclerosis patients with SOD1 mutations (2017) (13)
Endovascular Management of Symptomatic Cerebral Malperfusion Due to Carotid Dissection After Type A Aortic Dissection Repair (2011) (13)
Pyrimethamine Significantly Lowers CSF/SOD1 in ALS Patients With SOD1 Mutations (2017) (13)
Best practices protocol for the evaluation of bulbar dysfunction: summary recommendations from the NEALS bulbar subcommittee symposium (2018) (13)
Neurology and the COVID-19 emergency (2020) (13)
Bcl-2/adenovirus E1B 19-kDa interacting protein (BNip3) has a key role in the mitochondrial dysfunction induced by mutant huntingtin. (2015) (13)
Primary cultures of human caudate nucleus. (1988) (13)
Use of Noninvasive Ventilation During Feeding Tube Placement (2017) (13)
PON1 is a disease modifier gene in amyotrophic lateral sclerosis: association of the Q192R polymorphism with bulbar onset and reduced survival (2019) (12)
SURGICAL LESIONS, PARKINSONISM, AND BRAIN GRAFT OPERATIONS (1988) (12)
Structural MRI outcomes and predictors of disease progression in amyotrophic lateral sclerosis (2020) (12)
It won't happen to me! Psychosocial factors influencing risk perception for respiratory infectious diseases: A scoping review (2021) (12)
Toward a marker of upper motor neuron impairment in amyotrophic lateral sclerosis: A fully automatic investigation of the magnetic susceptibility in the precentral cortex. (2020) (12)
Ultrastructural mitochondrial abnormalities in patients with sporadic amyotrophic lateral sclerosis. (2011) (12)
Cognitive assessment of executive functions using brain computer interface and eye-tracking (2013) (12)
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design (2016) (12)
A neuro VR-Based version of the multiple errands test for the assessment of executive functions; (2009) (12)
GangliosideGM1 expression during human spinal cord and neural crest development. (1993) (12)
The role of de novo mutations in the development of amyotrophic lateral sclerosis (2017) (12)
MRI abnormalities found 1 year prior to symptom onset in a case of Creutzfeldt–Jakob disease (2016) (11)
Cryopreservation of human fetal adrenal medullary cells (1988) (11)
Detection of β-nerve growth factor mRNA in the human fetal brain (1990) (10)
Counterfactual Thinking Deficit in Huntington’s Disease (2015) (10)
Erythrocyte spectrofluorometric abnormalities in Duchenne patients and carriers (1979) (10)
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2014) (10)
SCFD1 expression quantitative trait loci in amyotrophic lateral sclerosis are differentially expressed (2021) (10)
NGF‐response of EGF‐dependent progenitor cells obtained from human sympathetic ganglia (1994) (10)
An old woman with pressure ulcer, rigidity, and opisthotonus: never forget tetanus! (2014) (9)
Structural MRI Signatures in Genetic Presentations of the Frontotemporal Dementia/Motor Neuron Disease Spectrum (2021) (9)
Amyotrophic lateral sclerosis: applications of stem cells – an update (2010) (9)
ORAL NEUROIMMUNE NETWORK AND MAST CELLS (2007) (9)
Clinical features and outcomes of the flail arm and flail leg and pure lower motor neuron MND variants: a multicentre Italian study (2020) (9)
SUMOylation Regulates TDP-43 Splicing Activity and Nucleocytoplasmic Distribution (2021) (9)
Brain Computer Interface and Eye-tracking for Neuropsychological Assessment of Executive Functions: A Pilot Study (2012) (9)
β-Nerve growth factor (β-NGF) mRNA expression in the Parkinsonian adrenal gland (1991) (9)
A novel nonsense ATP7A pathogenic variant in a family exhibiting a variable occipital horn syndrome phenotype (2017) (9)
Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter study (2020) (9)
Inefficient skeletal muscle oxidative function flanks impaired motor neuron recruitment in Amyotrophic Lateral Sclerosis during exercise (2017) (9)
Carotid Artery Stenting in Patients With Acute Coronary Syndrome: A Possible Primary Therapy for Symptomatic Carotid Stenosis (2013) (8)
No C9orf72 repeat expansion in patients with primary progressive multiple sclerosis. (2018) (8)
Deletion analysis of the simple tandem repeat loci physically linked to the spinal muscular atrophy locus (1996) (8)
Association of Clinically Evident Eye Movement Abnormalities With Motor and Cognitive Features in Patients With Motor Neuron Disorders (2021) (8)
Does metabolic syndrome influence short and long term durability of carotid endarterectomy and stenting? (2018) (7)
Genetics of primary lateral sclerosis (2020) (7)
Beta-nerve growth factor (beta-NGF) mRNA expression in the parkinsonian adrenal gland. (1991) (7)
Postzygotic instability of the myotonic dystrophy p[AGC]n repeat supported by larger expansions in muscle and reduced amplifications in sperm (1995) (7)
Amyotrophic lateral sclerosis phenotypes significantly differ in terms of magnetic susceptibility properties of the precentral cortex (2021) (7)
Genetic analysis of the SOD 1 and C 9 ORF 72 genes in Hungarian patients with amyotrophic lateral sclerosis (2017) (7)
The pathogenesis of ALS: implications for treatment strategies. (2001) (7)
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy (2015) (7)
Is diabetes a marker of higher risk after carotid revascularization? Experience from a single centre (2018) (7)
Identification of multiple transcribed sequences from the spinal muscular atrophy region of human chromosome 5. (1995) (7)
VPS54 genetic analysis in ALS Italian cohort (2011) (7)
Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions (2013) (7)
Sexuality and intimacy in ALS: systematic literature review and future perspectives (2018) (7)
TDP-43 and NOVA-1 RNA-binding proteins as competitive splicing regulators of the schizophrenia-associated TNIK gene. (2019) (7)
Upper motor neuron dysfunction is associated with the presence of behavioural impairment in patients with amyotrophic lateral sclerosis (2022) (7)
IPLEX and the Telephone Game: The difficulty in separating myth from reality on the internet (2009) (6)
Impact of obstructive sleep apnea on cardiac organ damage in patients with acute ischemic stroke (2018) (6)
Exosome microRNAs in Amyotrophic Lateral Sclerosis: A Pilot Study (2021) (6)
Motor neurone metabolism (1999) (6)
Adrenal medulla autograft in 3 parkinsonian patients: results using two different approaches. (1990) (6)
Atypical Parkinsonism Revealing a Late Onset, Rigid and Akinetic Form of Huntington's Disease (2011) (6)
Vascular and parenchymal lesions along with enhanced neurogenesis characterize the brain of asymptomatic stroke-prone spontaneous hypertensive rats (2013) (6)
Association of a Locus in the CAMTA 1 GeneWith Survival in PatientsWith Sporadic Amyotrophic Lateral Sclerosis (2016) (6)
Introducing Amyotrophic lateral sclerosis. (2011) (6)
Progression of cognitive and behavioral disturbances in motor neuron diseases assessed using standard and computer-based batteries (2021) (6)
The Compound Muscle Action Potential as Neurophysiological Marker for Amyotrophic Lateral Sclerosis. (2016) (6)
Molecular and phenotypical characterization of human amniotic fluid cells and their differentiation potential. (2008) (5)
Genome-wide study of DNA methylation in Amyotrophic Lateral Sclerosis identifies differentially methylated loci and implicates metabolic, inflammatory and cholesterol pathways (2021) (5)
Fiberoptic endoscopic evaluation of swallowing in early-to-advanced stage Huntington’s disease (2020) (5)
Behind the Scenes of COVID-19 Vaccine Hesitancy: Psychological Predictors in an Italian Community Sample (2022) (5)
A Computational Fluid Structure Interaction Study for Carotids with Different Atherosclerotic Plaques. (2021) (5)
Identification of the Raman Salivary Fingerprint of Parkinson’s Disease Through the Spectroscopic– Computational Combinatory Approach (2021) (5)
Detection of beta-nerve growth factor mRNA in the human fetal brain. (1990) (5)
Human Fetal Adrenal Medulla for Transplantation in Parkinsonian Patients (1987) (5)
Next-generation sequencing application to investigate skeletal muscle channelopathies in a large cohort of Italian patients (2020) (5)
Cerebrospinal fluid phosphorylated neurofilament heavy chain and chitotriosidase in primary lateral sclerosis (2020) (5)
The Effect of SMN Gene Dosage on ALS Risk and Disease Severity (2021) (5)
Naloxone of no benefit in amyotrophic lateral sclerosis (1983) (4)
ALS cerebrospinal fluid enhances human foetal astroglial cell proliferation in vitro. (1987) (4)
Human developing motor neurons as a tool to study ALS (2001) (4)
CSF angiogenin levels in amyotrophic lateral Sclerosis-Frontotemporal dementia spectrum (2019) (4)
Reliable change indices for the Italian Edinburgh Cognitive and Behavioral ALS Screen (ECAS) (2022) (4)
Diagnostic properties of the Italian ECAS Carer Interview (ECAS-CI) (2022) (4)
A preliminary comparison between ECAS and ALS-CBS in classifying cognitive–behavioural phenotypes in a cohort of non-demented amyotrophic lateral sclerosis patients (2021) (4)
Cognitive-constructivist Approach in Medical Settings: The Use of Personal Meaning Questionnaire for Neurological Patients’ Personality Investigation (2017) (4)
Preface: promoting research in PLS: current knowledge and future challenges (2020) (4)
Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation? (2017) (4)
Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations (2022) (4)
Genotypic and Phenotypic Heterogeneity in Amyotrophic Lateral Sclerosis (2018) (4)
Three-year outcomes after carotid artery revascularization: Gender-related differences (2019) (4)
Characterization of purified populations of human fetal chromaffin cells: considerations for grafting in parkinsonian patients. (1988) (4)
Reprogramming fibroblasts and peripheral blood cells from a C9ORF72 patient: A proof‐of‐principle study (2020) (4)
A susceptibility-weighted imaging qualitative score of the motor cortex may be a useful tool for distinguishing clinical phenotypes in amyotrophic lateral sclerosis (2020) (4)
Inter-Species Differences in Regulation of the Progranulin–Sortilin Axis in TDP-43 Cell Models of Neurodegeneration (2019) (3)
Emotional Processing and Experience in Amyotrophic Lateral Sclerosis: A Systematic and Critical Review (2021) (3)
Advance care planning and mental capacity in ALS: a current challenge for an unsolved matter (2020) (3)
Quantum Biology Research Meets Pathophysiology and Therapeutic Mechanisms: A Biomedical Perspective (2022) (3)
ePresentation Sessions (2020) (3)
Morphological Differentiation of Astroglial Progenitor Cells from Egf-Responsive Neurospheres in Response to Fetal Calf Serum, Basic Fibroblast Growth Factor, and Retinol (1996) (3)
A Novel Mutation of GFAP Causing Adult-Onset Alexander Disease (2019) (3)
Parkinsonian Syndromes in Motor Neuron Disease: A Clinical Study (2022) (3)
ROLE OF RISK SCORING SYSTEMS IN PREDICTING LIFE EXPECTANCY AFTER CAROTID ENDARTERECTOMY IN ASYMPTOMATIC PATIENTS. (2021) (3)
TMEM106B Acts as a Modifier of Cognitive and Motor Functions in Amyotrophic Lateral Sclerosis (2022) (3)
Impaired recognition of disgust in amyotrophic lateral sclerosis is related to basal ganglia involvement (2021) (3)
Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD) (2017) (3)
Genetic and epigenetic disease modifiers in an Italian C9orf72 family expressing ALS, FTD or PD clinical phenotypes (2021) (3)
Testing olfactory dysfunction in acute and recovered COVID-19 patients: a single center study in Italy (2021) (3)
The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration (2022) (3)
Counterfactual thinking in psychiatric and neurological diseases: A scoping review (2021) (2)
A reliable indirect cell-labelling protocol for optical imaging allows ex vivo visualisation of mesenchymal stem cells after transplantation. (2013) (2)
The significance of monoclonal gammopathy in motor neuron disease and related syndromes (1997) (2)
Mutations in the SPTLC1 gene are a cause of amyotrophic lateral sclerosis that may be amenable to serine supplementation (2019) (2)
Cerebral microbleeds: A new presenting feature of chromosome 22q11.2 deletion syndrome (2016) (2)
Human neuronal and paraneuronal cell viability demonstrated in vitro after cryopreservation and storage (1988) (2)
Human fetal brain β-nerve growth factor cDNA: molecular cloning of 5′ and 3′ untranslated regions (1991) (2)
Genetic characterization of a cohort with familial parkinsonism and cognitive-behavioral syndrome: A Next Generation Sequencing study. (2021) (2)
Characterization of the c9orf72 GC-rich low complexity sequence in two cohorts of Italian and Turkish ALS cases (2018) (2)
Resting state functional brain networks associated with emotion processing in frontotemporal lobar degeneration (2022) (2)
Therapy in Amyotrophic Lateral Sclerosis (ALS): an unexpected evolving scenario. (2017) (2)
CAMTA 1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis (2018) (2)
COVID-19 and supra-aortic trunks disease: review of literature about critical phase and sequelae. (2021) (2)
Oligoclonal immunoglobulins and immunoreactive myelin basic protein in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. (1985) (2)
Compensating for verbal-motor deficits in neuropsychological assessment in movement disorders: sensitivity and specificity of the ECAS in Parkinson’s and Huntington’s diseases (2021) (2)
Primary progressive aphasia and motor neuron disease: A review (2022) (2)
Antiphospholipid syndrome and systemic lupus erythematosus patients: what's new about cognitive involvement? (2009) (2)
Cognitive and behavioral involvement in ALS has been known for more than a century (2022) (2)
Molecular dynamics analysis of Superoxide Dismutase 1 mutations suggests decoupling between mechanisms underlying ALS onset and progression (2022) (2)
A Novel Approach for Investigating Parkinson’s Disease Personality and Its Association With Clinical and Psychological Aspects (2019) (2)
Mutations in the Sphingolipid Pathway Gene SPTLC1 are a Cause of Amyotrophic Lateral Sclerosis (2019) (1)
The oligogenic model of amyotrophic lateral sclerosis; phenotypes of three Tunisian families (2022) (1)
Diffusion Magnetic Resonance Imaging Microstructural Abnormalities in Multiple System Atrophy: A Comprehensive Review (2022) (1)
Lower semantic fluency scores and a phonemic-over-semantic advantage predict abnormal CSF P-tau181 levels in Aβ + patients within the Alzheimer’s disease clinical spectrum (2023) (1)
Validity and diagnostics of the Reading the Mind in the Eyes Test (RMET) in non-demented amyotrophic lateral sclerosis (ALS) patients (2022) (1)
Progressive motor neuron syndromes with single CNS lesions and CSF oligoclonal bands: never forget solitary sclerosis! (2022) (1)
Maintained cellular function of adrenal medullary cells in parkinsonian dysautonomia. (1991) (1)
Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: implications for reparative therapy in Parkinson’s disease (2011) (1)
Aortic arch types and postoperative outcomes after carotid artery stenting in asymptomatic and symptomatic patients. (2020) (1)
A + T ± status across MCI and dementia due to AD: a clinic-based, retrospective study (2022) (1)
Defining optimal management in ALS: Group discussion 3 (1999) (1)
Gaze-Contingent Eye-Tracking Training in Brain Disorders: A Systematic Review (2022) (1)
Neuroimmunology of human fetal brain in tissue culture (1985) (1)
Diagnostic properties of the Frontal Assessment Battery (FAB) in Huntington’s disease (2022) (1)
Cognitive Changes And White Matter Tract Damage In The Motor Neuron Disease Spectrum (P4.098) (2014) (1)
Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis (2022) (1)
Pallidal functional connectivity changes are associated with disgust recognition in pure motor amyotrophic lateral sclerosis (2022) (1)
Twenty-first Meeting of the European Neurological Society 28–31 May, 2011 (2011) (1)
Profiling morphologic MRI features of motor neuron disease caused by TARDBP mutations (2022) (1)
Do Women Have a Higher Risk of Adverse Events after Carotid Revascularization? (2018) (1)
Post stroke cognitive assessment and rehabilitation: A new ecological virtual reality task. (2009) (1)
Amyotrophic Lateral Sclerosis: Genotypes and Phenotypes (2014) (1)
Validity and reliability of the German language SF-36 health survey in patients with amyotrophic lateral sclerosis (2002) (1)
Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19 (2023) (1)
Human neuronal cells in culture: from concepts to basic methodology. (1990) (1)
Human substantia nigra in vitro as a bioassay for neurotrophic molecules of clinical significance. (1996) (1)
GRN−/− iPSC-derived cortical neurons recapitulate the pathological findings of both frontotemporal lobar degeneration and neuronal ceroidolipofuscinosis (2022) (1)
Psychometrics and diagnostics of the Italian version of the Beck Depression Inventory-II (BDI-II) in Parkinson’s disease (2023) (1)
Clinimetrics of the cognitive section of the Italian ALS Cognitive Behavioral Screen (ALS-CBS™) (2022) (1)
Screening of CHCHD10 in an Italian cohort of ALS/ALS-FTD patients (P2.051) (2015) (1)
Editorial on the original article entitled "Genetic validation of a therapeutic target in a mouse model of ALS" published in the Science Translational Medicine on August 6, 2014. (2015) (1)
rhIGF-I for the Treatment of Neuromuscular Disorders (1998) (1)
TARDBP mutations in a cohort of Italian patients with Parkinson’s disease and atypical parkinsonisms (2022) (1)
Repeated Courses of Bone Marrow-Derived Cell Mobilization Induced by Granulocyte-Colony Stimulating Factor (G-CSF) in Amyotrophic Lateral Sclerosis: Interim Analysis of a Prospective Multicenter Trial. (2007) (1)
Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB 1.0): development and normative data (2022) (1)
The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases (2023) (1)
Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis (2022) (1)
Telomere length analysis in amyotrophic lateral sclerosis using large-scale whole genome sequence data (2022) (1)
Chapter 20. Amyotrophic Lateral Sclerosis (2008) (1)
Expanding the phenotype of TARDBP mutation in a Tunisian family with clinical phenotype heterogeneity (2022) (1)
Virtual Multiple Errands Test: NeuroVR Supermarket (2018) (1)
Phenotypic Modulation and Neuroprotective Effects of Olfactory Ensheathing Cells: a Promising Tool for Cell Therapy (2015) (1)
Brain Functional Connectivity Disruption in a Large Cohort of Patients with Primary Progressive Aphasia (1517) (2020) (0)
Human fetal brain in tissue culture (1985) (0)
Genotype-phenotype correlation in Tunisian patients with Amyotrophic Lateral Sclerosis (2022) (0)
A case of amyotrophic lateral sclerosis associated with distal agenesis of an upper limb , hyperinsulinaemic hypoglycaemia , and hypocupraemia (2014) (0)
Impaired recognition of disgust is related to subcortical volume loss in amyotrophic lateral sclerosis (2021) (0)
Relationship between cerebrospinal fluid/serum albumin quotient and phenotype in amyotrophic lateral sclerosis: a retrospective study on 328 patients (2023) (0)
Generation of five induced pluripotent stem cells lines from four members of the same family carrying a C9orf72 repeat expansion and one wild-type member. (2022) (0)
Influence of contralateral carotid artery occlusions on short- and long-term outcomes of carotid artery stenting: a retrospective single-centre analysis and review of literature. (2020) (0)
Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts (2016) (0)
Report from the Italian Ministerial Committee regarding the diagnosis, care and assistance of patients with ALS (2005) (0)
Correction to: A susceptibility-weighted imaging qualitative score of the motor cortex may be a useful tool for distinguishing clinical phenotypes in amyotrophic lateral sclerosis (2020) (0)
Correction to: Unilateral freezing of gait or “magnetic feet phenomenon” caused by ischemic lesion involving fronto-striatal networks (2021) (0)
Clinical usability of the Story-Based Empathy Task (SET) in non-demented ALS patients. (2023) (0)
Activation of endogenous neurogenesis and neurorescue mechanism by human mesenchymal stem cells transplantation in an experimental model of Parkinson's Disease (2009) (0)
Has the association between ALS and FTD been actually acknowledged since the nineteenth century? (2022) (0)
Correction to: Motor, cognitive and behavioural profiles of C9orf72 expansion-related amyotrophic lateral sclerosis. (2023) (0)
Frontiers of amyotrophic lateral sclerosis cognitive assessment: The use of Eye-tracking and Brain Computer Interface in the eBrain project (2013) (0)
An ecologically-like virtual reality task for post stroke cognitive assessment and rehabilitation : preliminary data (2009) (0)
Neurological manifestations: an overview (2021) (0)
Molecules with neurotrophic effects on the human developing mesencephalic dopaminergic neurons. (1995) (0)
Structural MRI reveals distributed cortical thinning in patients with pure lower motor neuron disease variants (P6.091) (2015) (0)
Identification of FUS/TLS gene mutation in a cohort of Italian FALS patients (2009) (0)
Anti-MAG antibodies and antibody complexes in patients with peripheral neuropathy and IgM M-protein (1985) (0)
Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (2022) (0)
Mutations in ANXA11 cause familial and sporadic amyotrophic lateral sclerosis (2017) (0)
Relationship between Reaction Times and Post-COVID-19 Symptoms Assessed by a Web-Based Visual Detection Task (2023) (0)
Clinical features and outcomes of the flail arm and flail leg and pure lower motor neuron MND variants: a multicenter Italian study (2020) (0)
Diagnostics and clinical usability of the Montreal Cognitive Assessment (MoCA) in amyotrophic lateral sclerosis (2022) (0)
Contralateral myoclonus and bilateral parkinsonism after the ablation of a left frontal meningioma: A case report (1999) (0)
APS and the Nervous System (2015) (0)
Clinical and genetic spectrum of amyotrophic lateral sclerosis in a Tunisian series (2021) (0)
A comparative transcriptomic analysis of gastrocnemius and triceps muscles in an ALS mouse model (2007) (0)
ALS Genes: mutational analysis in a large cohort of Italian patients (2009) (0)
Generation of an iPSC line from a patient with spastic paraplegia type 10 carrying a novel mutation in KIF5A gene. (2022) (0)
Clinically evident ocular movement abnormalities are specific for cognitive impairment in amyotrophic lateral sclerosis (2021) (0)
Human Motor Neuron Obtained from iPSCs of the Peripheral Blood as the Most Promising Tool to Define Pathomechanisms and Novel Therapies in ALS (2019) (0)
Defined medium for purifying neuronal cells in culture from rat's central nervous tissue. (1982) (0)
Amyotrophic Lateral Sclerosis Bone Marrow Characterization (2009) (0)
Creatine Kinase serum levels in Motor Neuron Diseases Population: clinical and neurophysiological correlations (2007) (0)
The Frontal Assessment Battery (FAB) effectively discriminates between MCI and dementia within the clinical spectrum of neurochemically confirmed Alzheimer’s disease (2022) (0)
CPEO due to mutations in the tRNA for isolucine : two additional Italian cases. (2012) (0)
Cerebrospinal fluid/serum albumin quotient (Q-Alb) is not increased in Alzheimer’s disease compared to neurological disease controls: a retrospective study on 276 patients (2022) (0)
Vascular endothelial growth factor activity on mesenchymal stem cell during trans-differentiation towards neural phenotype : a possible link between neurogenesis and angigenesis (2005) (0)
Structural MRI signatures of grey matter atrophy in genetic frontotemporal lobar degeneration (2021) (0)
Phendimetrazine containing drugs induce transiet emiparesis (2008) (0)
CSF Aβ40 and P-Tau181 Might Differentiate Atypical from Typical AD Phenotypes: Preliminary Evidence (2022) (0)
Impaired recognition of disgust in amyotrophic lateral sclerosis is related to basal ganglia involvement (2021) (0)
Brain MRI signatures of atrophy in genetic frontotemporal lobar degeneration (2021) (0)
WHAT IS NEXT IN ALS CLINICAL TRIALS? Author's reply (2008) (0)
Genetic variability in sporadic amyotrophic lateral sclerosis. (2023) (0)
Seventeenth Meeting of the European Neurological Society 16–20 June 2007, Rhodes, Greece (2007) (0)
Novel THAP1 missense variant with incomplete penetrance in a case of generalized young onset dystonia showing good response to deep brain stimulation. (2022) (0)
DiGeorge Syndrome (2007) (0)
Insulin-like growth factor system in skeletal muscle in Amyotrophic Lateral Sclerosis (2008) (0)
Neurodegenerative Disease & Movement Disorders A clinical perspective into early stages of neurodegenerative disease (2013) (0)
Semiology and determinants of apathy across neurodegenerative motor disorders: A comparison between amyotrophic lateral sclerosis, Parkinson’s and Huntington’s disease (2022) (0)
Early endogenous neurogenesis activation in stroke-prone spontaneously hypertensive rat (SHRSP) precedes ischaemic events (2009) (0)
Platform Communications (2018) (0)
Equating norms between the ALS Cognitive Behavioral Screen (ALS-CBS™) and the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) in non-demented ALS patients. (2023) (0)
A multicentre trial G-CSF in Amyotrophic Lateral Sclerosis (2007) (0)
Pallidal functional connectivity changes are associated with disgust recognition in pure motor amyotrophic lateral sclerosis (2021) (0)
Neuroimaging in the Management of Motor Neuron Diseases (2011) (0)
Epileptic capgras-like delusions in a patient with right frontal meningioma. Case report (2021) (0)
Prominent upper motor neuron dysfunction correlates with a more significant behavioral impairment in patients with amyotrophic lateral sclerosis (2021) (0)
Effect of high altitude exposure on cognitive and psychological performance: data from the highcare project (2009) (0)
ALS genes: a mutational screening in a large cohort of Italian patients (2008) (0)
P79 TRACKING DISEASE PROGRESSION BY MRI: CLINICAL FEATURES OF AMYOTROPHIC LATERAL SCLEROSIS CORRELATE WITH FOCAL CORTICAL THINNING OF THE MOTOR CORTEX (2013) (0)
COGNITIVE FUNCTION UNDER EXPOSURE TO HYPOBARIC HYPOXIA AT ALTITUDE: DATA FROM THE HIGHCARE PROJECT: PP.4.136 (2010) (0)
Analysis of hematopoietic progenitor cells in ALS patients (2005) (0)
Facial nerve diplegia without ophthalmoplegia in a patient with anti-GQ1b antibodies (1999) (0)
A Pilot Trial of Clenbuterol in Spinal and Bulbar Muscular Atrophy (S36.003) (2013) (0)
Acquisition of the Immunophenotype by Human Adrenal Cells (1992) (0)
Can Pyrimethamine Lower CSF SOD1 Levels in Familial ALS? Results from a Multicenter Phase Ib Trial (S43.007) (2016) (0)
High conservation of the trinucleotide [CTG]n repeat at the myotonic dystrophy locus in nonhuman primates (1994) (0)
Translational research: possible explanations for the failure in ALS (2007) (0)
Novel bi-allelic FBXO7 variants in a family with early-onset typical Parkinson's disease. (2022) (0)
Emotional and autonomic response to visual erotic stimulation in patients with functional hypothalamic amenorrhea (2022) (0)
Arrows and Colors Cognitive Test (2019) (0)
Stem Cells in ALS: where are we? (2007) (0)
Onset and evolution of dysphagia in Huntington’s Disease (2019) (0)
The contribution of the Italian residents in neurology to the COVID-19 crisis: admirable generosity but neurological training remains their priority (2021) (0)
Cervical transverse MRI in ALS diagnosis and possible link to VEGF and MMP9 single nucleotide polymorphisms. Case Report (2020) (0)
Understanding the use of noninvasive ventilation in the treatment of amyotrophic lateral sclerosis in the US and Europe: results of an international physician survey (P5.071) (2017) (0)
In Vitro and In Vivo Mesenchymal Stem Cells Neurotrophin Production but Limited Neuronal Differentiation. (2005) (0)
A PHASE I-II MULTICENTRE STUDY ON G-CSF IN AMYOTROPHIC LATERAL SCLEROSIS (STEMALS) (2007) (0)
Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem) (2022) (0)
Pramipexole treatment in a late-onset Huntington's disease patient (2006) (0)
The Italian dementia with lewy bodies study group (DLB-SINDEM): A multicenter survey on the accuracy and the prevalence of DLB diagnosis (2021) (0)
The Effects of a New Integrated and Multidisciplinary Cognitive Rehabilitation Program Based on Mindfulness and Reminiscence Therapy in Patients with Parkinson’s Disease and Mild Cognitive Impairment: A Pilot Study (2023) (0)
Correction to: Psychometrics and diagnostics of the Italian version of the Beck Depression Inventory-II (BDI-II) in Parkinson's disease. (2023) (0)
Association of the risk factor UNC13A with survival and upper motor neuron involvement in amyotrophic lateral sclerosis (2023) (0)
Safety and Efficacy of the New Micromesh‐Covered Stent CGuard in Patients Undergoing Carotid Artery Stenting: Early Experience From a Single Centre (2018) (0)
The neuro-glial potential of chrionic villi and amniotic fluid-derived cells could effectively promote neurorescue in Parkinson's disease cell models? (2009) (0)
Functional Connectivity From Disease Epicenters in Frontotemporal Dementia. (2023) (0)
Correction to: Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis. (2023) (0)
A13 Mutant huntingtin induces activation of Bcl-2/adenovirus E1B 19-kDa interacting protein (BNIP3) (2010) (0)
A nationwide survey on clinical neurophysiology education in Italian schools of specialization in neurology (2021) (0)
ANTI-GQ1b ANTIBODIES IN A PATIENT WITH FACIAL NERVE DIPLEGIA WITHOUT OPHTHAMOLPLEGIA (2000) (0)
Characterization of FTLD spectrum through advanced diffusion-weighted MRI metrics: a connectome approach (P11-6.003) (2023) (0)
Presence of CD34+cells in the CSF after G-CSF induced mobilisation and mannitol treatment in patients with amyotrophic lateral sclerosis (2011) (0)
Modeling Electric Fields in Transcutaneous Spinal Direct Current Stimulation: A Clinical Perspective (2023) (0)
Motor, cognitive and behavioural profiles of C9orf72 expansion-related amyotrophic lateral sclerosis (2022) (0)
Macular preservation with bilateral visual field defect caused by embolic occlusion of the posterior cerebral arteries (1999) (0)
Frontotemporal syndromes of primary lateral sclerosis (2012) (0)
Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis (2023) (0)
The diagnostic value of cortical thickness measures and diffusion tensor MRI metrics in the clinical phenotypes of MND (P6.088) (2015) (0)
Muscle proteomic profile in the transgenic SOD1G93A mouse and in ALS patients (2007) (0)
Induction Of Chronic Stress Reveals An Interplay Of Stress Granules And TDP-43 Pathological Aggregates In Human ALS Fibroblasts And iPSC-Neurons (2020) (0)
Converging longitudinal patterns of atrophy in clinical variants of frontotemporal lobar degeneration (2021) (0)
Functional alteration of bone marrow mesenchymal stem cells of Amyotrophic Lateral Sclerosis Patients (2009) (0)
Carotid artery stenting is safe and effective for symptomatic patients with acute coronary syndrome (2020) (0)
Are olfactory ensheathing cells a promising cell therapy tool (2014) (0)
In vivo and in vitro Development of Human Mesencephalic Dopaminergic Neurons (1992) (0)
Cerebral amyloid angiopathy (CAA): search for pathogenetic mutations in sporadic cases (2012) (0)
Italian reference values and brain correlates of verbal fluency index - vs standard verbal fluency test - to assess executive dysfunction in ALS. (2023) (0)
Telemedicine in Neuromuscular Diseases During Covid-19 Pandemic: ERN-NMD European Survey. (2022) (0)
Neurological disorders associated with COVID-19 infection: An Italian multi-center cohort study (NEURO-COVID) (2021) (0)
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension^Chinese Hypertension League Stroke in Hypertension OptimalTreatment randomized trial (2014) (0)
Red cell abnormalities in Huntington's disease (1978) (0)
Large-scale analyses of CAV1 and CAV2 suggest their expression is higher in post-mortem ALS brain tissue and affects survival (2022) (0)
Identification of new HSPB8 variants linked to familial Amiotrophic Lateral Sclerosis (2018) (0)
Tau mutations lead to chromosome aberrations: A new role of tau in the pathogenesis of genetic tauopathies? (2010) (0)
Mutation analysis of the VPS54 gene in ALS patients (2008) (0)
Standardization of the Italian ALS-CBS™ Caregiver Behavioral Questionnaire (2023) (0)
' s response to reviews Title : Weight loss , dysphagia and supplement intake in patients with amyotrophic lateral sclerosis ( ALS ) : Impact on quality of life and therapeutic options (2013) (0)
Unilateral freezing of gait or “magnetic feet phenomenon” caused by ischemic lesion involving fronto-striatal networks (2021) (0)
Title: Mutations in ANXA11 cause familial and sporadic amyotrophic lateral sclerosis (2016) (0)
Microarray analysis of the skeletal muscle from a transgenic mouse model of ALS (2005) (0)
Cardiovascular diseases may play a negative role in the prognosis of ALS (2018) (0)
Epileptic Capgras-Like Delusions in a Patient with Right Frontal Meningioma: Case Report (2021) (0)
Analysis of miRNA rare variants in amyotrophic lateral sclerosis and in silico prediction of their biological effects (2022) (0)
Fluid structure interaction analysis to stratify the behavior of different atheromatous carotid plaques. (2022) (0)
Optineurin gene mutations in a color of Italian amyotrophic lateral sclerosis patients (2011) (0)
Correction: Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I‑UDSNB 1.0): development and normative data (2023) (0)
A NeuroVR based version of the Multiple Errands Test for the assessment of executive functionss in patients with different etiologies (2010) (0)
CHANGE IN COGNITIVE FUNCTIONS DURING ACUTE EXPOSURE TO HYPOBARIC HYPOXIA AT HIGH ALTITUDE: 5B.07 (2011) (0)
White Matter Damage in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis: A Tract-Based Spatial Statistics Study (P03.162) (2012) (0)
Feasibility and diagnostics of the Frontal Assessment Battery (FAB) in amyotrophic lateral sclerosis (2022) (0)
The Diagnostic Value Of Diffusion Tensor MRI Metrics In Relation To The MND Phenotype Heterogeneity (P7.007) (2014) (0)
Red cell membrane abnormality in carriers of Duchenne muscular dystrophy (DMD) (1978) (0)
European Handbook of Neurological Management (2010) (0)
NMR Metabolomics for Stem Cell type discrimination (2017) (0)
Morphological studies and quantitative assessment of the effect of chick embryo extract on monolayer cultures of normal human muscle. (1982) (0)
F34 Anosognosia of motor deficits in Huntington’s disease (2022) (0)
Human cord blood cells reduce symptoms progression and neuromuscular decay in a murine model of motoneuron disease, the wobbler mouse (2007) (0)
SOD1 Gene mutations in Italian Amyotrophic Lateral Sclerosis Patients (2007) (0)
Human mesenchymal stem cell implant in a rodent Parkinson's model : preliminary results from an in vitro and in vivo study (2007) (0)
Loss of Parkin Protein causes abnormal intracellular calcium levels upon glutamatergic stimulation in neuronal cells (2009) (0)
Response to the commentary "The effect of C9orf72 intermediate repeat expansions in neurodegenerative and autoimmune diseases" by Biasiotto G and Zanella I.✰. (2019) (0)
ALS: Current theories of pathogenesis (1997) (0)
Prolonged cognitive deficits after COVID-19 (2021) (0)
Prevalence and determinants of language impairment in non‐demented amyotrophic lateral sclerosis patients (2022) (0)
Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson’s disease patients (2023) (0)
Regional spreading pattern is associated with clinical phenotype in amyotrophic lateral sclerosis. (2023) (0)
Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation? (2017) (0)
Title : Phosphorylated neurofilament heavy chain : a biomarker of survival for C 9 ORF 72-associated amyotrophic lateral sclerosis (2017) (0)
Muscle mitochondrial oxidative defects in Amyotrophic Lateral Scelosis (2007) (0)
A sporadic case of amyotrophic lateral sclerosis-parkinsonism (1999) (0)
Pre-proof New technologies and Amyotrophic Lateral Sclerosis – Which step forward rushed by the COVID-19 pandemic ? (2020) (0)
Gene expression profiling of skeletal muscle from SOD1G93A transgenic mouse (2007) (0)
Insulin-like Growth Factor-1 profiling in Amyotrophic Lateral Sclerosis (ALS) (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Vincenzo Silani?

Vincenzo Silani is affiliated with the following schools:

University of Milan